Home › NCT07222085
Long-Term Stability of the Glide Control Strategy
Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Unilateral trans-radial or trans-humeral limb loss with a healed residual limb * Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist * Age of 18 years or greater Exclusion Criteria: * Prior experience with Pattern Recognition or Glide control * Individuals with a residual limb that is unhealed from the amputation surgery * Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes * Significant cognitive deficits as determined upon clinical evaluation * Significant neurological deficits as determined upon clinical evaluation * Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation * Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation * Serious uncontrolled medical problems
About the study
This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinically relevant knowledge to inform the prescription of prosthesis components and the rehabilitation process.
What is being tested
- Glide Control System (device)
- Pattern Recognition System (device)
Sponsor: Infinite Biomedical Technologies · Participants: 12 · Started: Oct 15, 2025
Contact the study team
- Christopher Hunt, Ph.D · Phone: +1 443-451-7175
Official record on ClinicalTrials.gov — NCT07222085
Locations in the U.S.
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.